Ipca Laboratories Dividend
Dividend criteria checks 2/6
Ipca Laboratories is a dividend paying company with a current yield of 0.15% that is well covered by earnings.
Key information
0.1%
Dividend yield
9%
Payout ratio
Industry average yield | 0.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | ₹22.24 |
Dividend yield forecast in 3Y | 0.5% |
Recent dividend updates
Recent updates
Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16The Case For Ipca Laboratories Limited (NSE:IPCALAB): Could It Be A Nice Addition To Your Dividend Portfolio?
Dec 13This Insider Has Just Sold Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Nov 28Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Nov 25Ipca Laboratories Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 10Is Ipca Laboratories Limited's (NSE:IPCALAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Nov 08Do Insiders Own Lots Of Shares In Ipca Laboratories Limited (NSE:IPCALAB)?
Oct 24Ipca Laboratories' (NSE:IPCALAB) Wonderful 327% Share Price Increase Shows How Capitalism Can Build Wealth
Oct 09What We Learned About Ipca Laboratories' (NSE:IPCALAB) CEO Compensation
Sep 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: IPCALAB's dividend payments have been volatile in the past 10 years.
Growing Dividend: IPCALAB's dividend payments have not increased over the past 10 years.
Dividend Yield vs Market
Ipca Laboratories Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (IPCALAB) | 0.1% |
Market Bottom 25% (IN) | 0.3% |
Market Top 25% (IN) | 1.2% |
Industry Average (Pharmaceuticals) | 0.7% |
Analyst forecast in 3 Years (IPCALAB) | 0.5% |
Notable Dividend: IPCALAB's dividend (0.15%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.26%).
High Dividend: IPCALAB's dividend (0.15%) is low compared to the top 25% of dividend payers in the Indian market (1.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (9%), IPCALAB's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (19.4%), IPCALAB's dividend payments are well covered by cash flows.